Afstyla recombinant and Treprostinil Extended-Release Tablets
Determining the interaction of Afstyla recombinant and Treprostinil Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Afstyla (recombinant)
Generic Name: treprostinil
Brand name: Orenitram, Remodulin, Tyvaso, Tyvaso Refill Kit, Tyvaso Starter Kit
Synonyms: Treprostinil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Afstyla recombinant-Treprostinil inhalation
- Afstyla recombinant-Treprostinil injection
- Afstyla recombinant-Treprostinil Injection Solution
- Afstyla recombinant-Treprostinil Oral Inhalation Solution
- Afstyla recombinant-Treprostinil Sodium
- Afstyla recombinant-Tresiba
- Treprostinil Extended-Release Tablets-Aftera
- Treprostinil Extended-Release Tablets-Aftertest Topical Pain Relief
- Treprostinil Extended-Release Tablets-Agalsidase beta
- Treprostinil Extended-Release Tablets-Agalsidase beta Intravenous
- Treprostinil Extended-Release Tablets-Agenerase
- Treprostinil Extended-Release Tablets-Aggrastat